The core risk is sequencing. Stem must keep enough liquidity to reach the point where higher-margin software, controls, and services clearly dominate the story. If Hungary and other hybrid wins become repeatable proof points, the equity can
rerate sharply; if
backlog conversion slips, refinancing terms worsen, or
OEM-native stacks commoditize the control layer, much of the operating improvement can be absorbed before common shareholders benefit.